US Capitol Capsule: Obama pushes for crowdfunding, while SEC panel cautious
This article was originally published in Scrip
After talking about it in his 2011 and 2012 State of the Union addresses and numerous speeches throughout the past year, President Barack Obama last week finally sent Congress his legislative agenda aimed at expanding access to capital and cutting taxes for US biotechs and other startups and small businesses (scripintelligence, 1 February 2011, 26 January 2012).
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.